Steven M. Paul
Director at Rapport Therapeutics · 3 reported transactions in 1 company · latest trade Oct 22, 2026
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +27.3%, S&P 500 +2.3% over the same days.
Their trades
Bought | Oct 22, 2026 | Oct 22, 2026 close $26.53 → Oct 28, 2026 close $22.50. S&P 500 +0.8% over the same days. | ||
Bought | Sep 12, 2025 | Sep 12, 2025 close $23.76 → Oct 28, 2026 close $22.50. S&P 500 +17.1% over the same days. | ||
Bought | Sep 12, 2025 | Sep 12, 2025 close $23.76 → Oct 28, 2026 close $22.50. S&P 500 +17.1% over the same days. |
BoughtRapport Therapeutics
$974.3K
Oct 22, 2026 close $26.53 → Oct 28, 2026 close $22.50. S&P 500 +0.8% over the same days.
BoughtRapport Therapeutics
$334.2K
Sep 12, 2025 close $23.76 → Oct 28, 2026 close $22.50. S&P 500 +17.1% over the same days.
BoughtRapport Therapeutics
$692.9K
Sep 12, 2025 close $23.76 → Oct 28, 2026 close $22.50. S&P 500 +17.1% over the same days.